0
Commentary |

Components Necessary for High-Quality Lung Cancer ScreeningQuality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement

Peter Mazzone, MD, MPH, FCCP; Charles A. Powell, MD; Douglas Arenberg, MD, FCCP; Peter Bach, MD; Frank Detterbeck, MD, FCCP; Michael K. Gould, MD, FCCP; Michael T. Jaklitsch, MD; James Jett, MD, FCCP; David Naidich, MD, FCCP; Anil Vachani, MD; Renda Soylemez Wiener, MD; Gerard Silvestri, MD, FCCP
Author and Funding Information

From the Respiratory Institute (Dr Mazzone), Cleveland Clinic, Cleveland, OH; the Division of Pulmonary, Critical Care, and Sleep Medicine (Dr Powell), Icahn School of Medicine at Mount Sinai, New York, NY; the Division of Pulmonary and Critical Care Medicine (Dr Arenberg), University of Michigan, Ann Arbor, MI; the Center for Health Policy and Outcomes (Dr Bach), Memorial Sloan-Kettering Cancer Center, New York, NY; the Section of Thoracic Surgery (Dr Detterbeck), Yale, New Haven, CT; Department of Research and Evaluation (Dr Gould), Kaiser Permanente Southern California, Pasadena, CA; the Division of Thoracic Surgery (Dr Jaklitsch), Brigham and Womens Hospital, Boston, MA; the Division of Oncology (Dr Jett), National Jewish Health, Denver, CO; the Department of Radiology (Dr Naidich), NYU Langone Medical Center, New York, NY; the Pulmonary, Allergy, & Critical Care Division (Dr Vachani), University of Pennsylvania, Philadelphia PA; the Center for Healthcare Organization and Implementation Research (Dr Wiener), Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA; The Pulmonary Center (Dr Wiener), Boston University School of Medicine, Boston, MA; and the Division of Pulmonary and Critical Care (Dr Silvestri), Medical University of South Carolina, Charleston, SC.

CORRESPONDENCE TO: Peter J. Mazzone, MD, MPH, FCCP, 9500 Euclid Ave, A90, Cleveland, OH 44195; e-mail: mazzonp@ccf.org


Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2015;147(2):295-303. doi:10.1378/chest.14-2500
Text Size: A A A
Published online

Lung cancer screening with a low-dose chest CT scan can result in more benefit than harm when performed in settings committed to developing and maintaining high-quality programs. This project aimed to identify the components of screening that should be a part of all lung cancer screening programs. To do so, committees with expertise in lung cancer screening were assembled by the Thoracic Oncology Network of the American College of Chest Physicians (CHEST) and the Thoracic Oncology Assembly of the American Thoracic Society (ATS). Lung cancer program components were derived from evidence-based reviews of lung cancer screening and supplemented by expert opinion. This statement was developed and modified based on iterative feedback of the committees. Nine essential components of a lung cancer screening program were identified. Within these components 21 Policy Statements were developed and translated into criteria that could be used to assess the qualification of a program as a screening facility. Two additional Policy Statements related to the need for multisociety governance of lung cancer screening were developed. High-quality lung cancer screening programs can be developed within the presented framework of nine essential program components outlined by our committees. The statement was developed, reviewed, and formally approved by the leadership of CHEST and the ATS. It was subsequently endorsed by the American Association of Throacic Surgery, American Cancer Society, and the American Society of Preventive Oncology.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543